Cardiovascular and Metabolic Market Overview Forecast Model

Cardiovascular and Metabolic Market Overview Forecast Model


January 26, 2010
19 Pages - SKU: DFMN2578707
License type:
Online Download      US $15,200.00
Global Site License      US $38,000.00
Introduction

Datamonitor expects antidiabetic therapies to emerge as the biggest revenue earner in the cardiovascular and metabolic markets by 2018. A large and diverse development pipeline will provide a number of new blockbuster drugs but the heavy genericization of the hypertension and dyslipidemia primary care markets will lead to the overall market only growing by 0.9% in the seven major markets.

Reasons to Purchase
  • Qualify and quantify the Top 10 cardiovascular therapy brands across the seven major pharmaceutical markets from 2008 to 2018.
  • Understand key drivers and predict the future performance of leading products.
  • Assess the remaining market opportunities, where established therapies and other developmental compounds fail to address key unmet clinical needs.
Please note: this is delivered as a Zip file.



More Endocrinology/Metabolics reports by Datamonitor

Market and Product Forecasts: HER2-Negative/Hormone Receptor-Positive Breast Cancer - Patent expiries and novel drugs shape the market in the next decade by Datamonitor
IntroductionThe treatment of HER2-negative/hormone receptor-positive breast cancer consists largely of genericized cytotoxic and antihormonal therapies. Avastin (bevacizumab) is currently the only targeted therapy used in ...
Pipeline and Commercial Insight: Testosterone Replacement Therapy - Topical formulations drive market growth by Datamonitor
IntroductionThe testosterone replacement therapy market grew with an impressive compound annual growth rate [CAGR]: 24.3% from 2005 to 2009 to reach $838m sales. While these ...
Pipeline and Commercial Insight: Hormonal Replacement Therapy for Menopausal Symptoms - Safety fears continue to haunt the market by Datamonitor
IntroductionSales of hormone replacement therapies treating menopausal symptoms have seen a sharp decline in recent years as a result of safety concerns raised by the ...
Testosterone Replacement Therapy Market Forecast by Datamonitor
IntroductionThe testosterone replacement therapy market grew with an impressive compound annual growth rate [CAGR]: 24.3% from 2005 to 2009 to reach $838m sales. While these ...
See all reports like this >>